Member Info for Sisyphus

From its introduction to tomorrow's sellout symposium:

Exciting advancements in epigenetics are transforming clinical research! Discover how DNA methylation and histones discoveries, using nanopore technology, are aiding cancer research, anti-obesity drugs, & age-related disease

Conference Weds. This has been driven down upto this point and I'm happy to load up at my 106.5 paid. I consider it a perfect entry level now for a good short term and excellent medium term gain. Time will tell.

I expect updated information and progress in nanopore tech provided at Weds sellout conference to start rerate here. Darned sure bioMerieux and Illumina will be watching closely as will other big players. The former showed its hand last October by snapping up 7% and I expect a few others will start to position as the 3 year takeover lockout expires. Great British Company that could do with British institutional support before its swallowed by France or the USA.

Hopefully make it 3 in 3 months. Posted KNOS at 997 then VOD at 68 and onto ONT at 110. Two soared one pending.

The fact that all tickets have been sold out is an indicator of the huge interest in Oxford Nano and its groundbreaking tech. The 3 year takeover protection built into the IPO in 2021 ends this year and bioMerieux snapped up 7% in October. Interesting times ahead.

No support from British funds to keep the momentum.... shameful. Hopefully a Stateside or French acquirer will show them just how cutting-edge and must-have this tech is.

All three factors needed to drive this back to 'infinity and beyond' are in play ..... plus we now have fomo!

120p looking achievable today given momentum....

Buying pressure, volume and multie attempts to break the 114.2.......this time we succeed.

Big increase in volumes over last 5 trading sessions on NYSE and building nicely early-on here. Expecting a nice little gap-jump soon.

Chart is looking good for a concerted attack on 120p as the next hurdle.....

Https://nanoporetech.com/about/events/conferences/lc24

Oxford Nanotech are centre stage at London conference next Wednesday 22nd May so should provide good platform from here.

It's the groundbreaking innovators that will mold the future. The NHS will be driven by the likes of ONT.

https://www.england.nhs.uk/healthcare-science/personalisedmedicine/

Oxford Nano is like early AI in that it is on the cusp of transforming the future. Personalised medicine is here and will explode in the next decade. Oxford Nano is breaking all the moulds as its tech opens the doors. It has the cash and runway. Hold tight as the likes of bioMerieux and other big pharmas eye up how they can get hold of this IP. Interesting times ahead imo.

Anti-takeover protection ends this year and the share price is a quarter of that at IPO in 2021.

Slaughter and May

Devised anti-takeover IPO strategy for Oxford Nano - float price £4.25 per share.

We helped design and implement ONT’s innovative takeover-defence We helped design and implement ONT’s innovative takeover-defence share structure, granting the CEO (or certain replacements, in the event of the CEO no longer being available) voting control of ONT in the event of an undesired takeover or other change of control for three years post-IPO.ements, in the event of the CEO no longer being available) voting control of ONT in the event of an undesired takeover or other change of control for three years post-IPO.

..........the IPO was in 2021......it is now 2024.

Can't believe this is still hovering around this low level when June 6th signals a time that stakebuilding and takeover stakes rise post IPO. Grossly undervalued as recent director buys appear to agree.

Looking interesting. US investors seeing value - or stake building??

Big jump in traded volume on NYSE today...over 535% above 65 day average. Interesting.....it's been around 25% over past 2 weeks.